My Account Log in

1 option

CADTH Canadian Drug Expert Committee recommendation : Ozenoxacin 1% cream (Ozanex - Ferrer Internacional, S.A.) : indication: the topical treatment of impetigo in patients aged two months and older / CADTH Canadian Drug Expert Committee.

NCBI Bookshelf Available online

View online
Format:
Book
Author/Creator:
CADTH Canadian Drug Expert Committee, author.
Series:
Common drug review clinical review report.
Common drug review clinical review report
Language:
English
Subjects (All):
Drugs Cost effectiveness.
Drugs.
Outcome assessment (Medical care).
Physical Description:
1 online resource.
Edition:
Final edition.
Place of Publication:
Ottawa, ON : Canadian Agency for Drugs and Technologies in Health, 2018.
Summary:
The CADTH Canadian Drug Expert Committee (CDEC) recommends that ozenoxacin not be reimbursed for the treatment of impetigo.
Notes:
Description based on publisher supplied metadata and other sources.

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account